Monday June 26th 2017

Archive for December, 2014

Fractional photothermolysis treatment of digital cutis laxa reverses hand disability

Fractional photothermolysis treatment of digital cutis laxa reverses hand disability

Abstract In this case study, we present a safe and novel treatment for a patient with soft tissue hand disability caused by severe and chronic lupus and cutis laxa (CL). This patient was a woman in her 50s with a 20‐year history of systemic lupus erythematous (SLE) and [Read More]

Heterogeneity of Multiple Sclerosis White Matter Lesions Detected With T2*‐Weighted Imaging at 7.0 Tesla

Heterogeneity of Multiple Sclerosis White Matter Lesions Detected With T2*‐Weighted Imaging at 7.0 Tesla

CONCLUSIONSWM‐Ls with a contour of high R2* are present at different MS stages, potentially representing differences in the contribution of iron in MS disease evolution. (Source: Journal of Neuroimaging) [Read More]

Comparison of the Affective Symptomatology Between Liver Transplant Recipients and Patients With Multiple Sclerosis Considering Their Functional…

Comparison of the Affective Symptomatology Between Liver Transplant Recipients and Patients With Multiple Sclerosis Considering Their Functional…

We aimed to compare the affective symptomatology in two medical conditions under immunotherapy (cadaveric liver transplantation and multiple sclerosis ), considering their functional impairment, and to assess the clinical significance of the results regarding a [Read More]

 Page 1 of 142  1  2  3  4  5 » ...  Last » 

Latest Topics

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]

MS Society Disappointed with Senate Healthcare Bill

MS Society Disappointed with Senate Healthcare Bill

/About-the-Society/News/HealthcareBill-6-22 [Read More]

Best multiple sclerosis blogs

Best multiple sclerosis blogs

Multiple sclerosis blogs are both helpful and inspirational for people affected by the disease. We have selected the 10 [Read More]